{
    "Trade/Device Name(s)": [
        "NeoBase 2 Non-derivatized MSMS kit"
    ],
    "Submitter Information": "Wallac Oy, Subsidiary of PerkinElmer, Inc.",
    "510(k) Number": "K173568",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093916"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQL"
    ],
    "Summary Letter Date": "August 24, 2018",
    "Summary Letter Received Date": "August 27, 2018",
    "Submission Date": "August 24, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1055"
    ],
    "Regulation Name(s)": [
        "Newborn screening test system for amino acids, free carnitine, and acylcarnitines using tandem mass spectrometry"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine",
        "toxicology"
    ],
    "Analyte(s)": [
        "Alanine",
        "Arginine",
        "Argininosuccinic acid",
        "Citrulline",
        "Glutamine",
        "Lysine",
        "Glutamic acid",
        "Glycine",
        "Leucine",
        "Isoleucine",
        "Hydroxyproline",
        "Methionine",
        "Ornithine",
        "Phenylalanine",
        "Proline",
        "Tyrosine",
        "Valine",
        "Free carnitine",
        "Acetylcarnitine",
        "Propionylcarnitine",
        "Malonylcarnitine",
        "3-Hydroxy-butyrylcarnitine",
        "Butyrylcarnitine",
        "Methylmalonylcarnitine",
        "3-Hydroxy-isovalerylcarnitine",
        "Isovalerylcarnitine",
        "Tiglylcarnitine",
        "Glutarylcarnitine",
        "3-Hydroxy-hexanoylcarnitine",
        "Hexanoylcarnitine",
        "Adipylcarnitine",
        "Octanoylcarnitine",
        "Octenoylcarnitine",
        "Decanoylcarnitine",
        "Decenoylcarnitine",
        "Decadienoylcarnitine",
        "Dodecanoylcarnitine",
        "Dodecenoylcarnitine",
        "Tetradecanoylcarnitine",
        "Tetradecenoylcarnitine",
        "Tetradecadienoylcarnitine",
        "3-Hydroxy-tetradecanoylcarnitine",
        "Hexadecanoylcarnitine",
        "Hexadecenoylcarnitine",
        "3-Hydroxy-hexadecanoylcarnitine",
        "3-Hydroxy-hexadecenoylcarnitine",
        "Heptadecanoylcarnitine",
        "Octadecanoylcarnitine",
        "Octadecenoylcarnitine",
        "Octadecadienoylcarnitine",
        "3-Hydroxy-octadecanoylcarnitine",
        "3-Hydroxy-octadecenoylcarnitine",
        "3-Hydroxy-octadecadienoylcarnitine",
        "Succinylacetone",
        "Adenosine",
        "2'-deoxyadenosine",
        "C24:0 lysophosphatidylcholine",
        "C26:0 lysophosphatidylcholine"
    ],
    "Specimen Type(s)": [
        "Newborn heel prick blood specimens dried on filter paper"
    ],
    "Specimen Container(s)": [
        "Filter paper"
    ],
    "Instrument(s)/Platform(s)": [
        "Tandem mass spectrometer",
        "TQD (Tandem Quadrupole Detector)"
    ],
    "Method(s)/Technology(ies)": [
        "Tandem mass spectrometry"
    ],
    "Methodologies": [
        "Quantitative analysis of metabolite concentrations"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for NeoBase 2 Non-derivatized MSMS kit for newborn screening using tandem mass spectrometry of dried blood spots.",
    "Indications for Use Summary": "Intended for measurement and evaluation of amino acids, succinylacetone, free carnitine, acylcarnitines, nucleosides, and lysophospholipids from newborn heel prick blood dried on filter paper to aid in screening for metabolic disorders.",
    "fda_folder": "Clinical Chemistry"
}